Gilead questions WHO study that cast doubts on drug’s Covid-19 benefits, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drug’s benefits., The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drug’s benefits., , Read More

Leave a Reply

Your email address will not be published.